510(k) · Cleared
Recalled · Class II · 2019Modification to: Unicap Specific Ige
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Pharmacia Diagnostics AB · DHB System, Test, Radioallergosorbent (Rast) Immunological
Cleared on Jun 9, 2005 as substantially equivalent to K962274 (Pharmacia, Inc., 1996) after a 28-day review. Its family tree reaches back 1 generation to 1996. 30 later devices descend from it. It has been recalled 3 times.
- Decided
- Jun 9, 2005
- Review
- 28 days
- Class
- Class II
- Product code
- DHB
- Recalls
- 3
- Predicates
- 1
Its longest line of descent runs back 1 generation to K962274 (1996). 30 later devices descend from it, 27 citing it directly.
- Root · 1 generation backK962274 Unicap 100Pharmacia, Inc. · 1996
- This deviceK051218 Modification to: Unicap Specific IgePharmacia Diagnostics AB · 2005
- Descendant · cites it directly · 1 of its ownK161899 ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip…Phadia AB · 2016 · Recalled
- Descendant · cites it directly · 1 of its ownK113841 Immunocap Allergen Components BundlePhadia US, Inc. · 2012
- Descendant · cites it directly · 1 of its ownK101251 Immunocap Allergen D202, Allergen Component Nder P 1, House Dust…Phadia AB · 2011
- Descendant · cites it directly · 0 of its ownK261027 NOVEOS Specific IgE (sIgE); Capture Reagent F014, Soybean (Glycine…Hycor Biomedical · 2026
- Descendant · cites it directly · 0 of its ownK260591 NOVEOS Specific IgE (sIgE);Capture Reagent F010, Sesame Seed…Hycor Biomedical · 2026
Showing 5 of 30 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 30 · See all- K161899ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip, ImmunoCAP Total IgE…Phadia AB · 2016 · cites it directly1descendant
- K113841Immunocap Allergen Components BundlePhadia US, Inc. · 2012 · cites it directly1descendant
- K101251Immunocap Allergen D202, Allergen Component Nder P 1, House Dust Mite, Immunocap…Phadia AB · 2011 · cites it directly1descendant
- K261027NOVEOS Specific IgE (sIgE); Capture Reagent F014, Soybean (Glycine max); Capture Reagent…Hycor Biomedical · 2026 · cites it directly0descendants
- K260591NOVEOS Specific IgE (sIgE);Capture Reagent F010, Sesame Seed (Sesamum indicum);Capture…Hycor Biomedical · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K962274 | Unicap 100 | Pharmacia, Inc. | 1996 | — |
| 0 (this device) | K051218 | Modification to: Unicap Specific Ige | Pharmacia Diagnostics AB | 2005 | — |
| +1 | K161899 | ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip, ImmunoCAP… | Phadia AB | 2016 | 1 |
| +1 | K113841 | Immunocap Allergen Components Bundle | Phadia US, Inc. | 2012 | — |
| +1 | K101251 | Immunocap Allergen D202, Allergen Component Nder P 1, House Dust Mite… | Phadia AB | 2011 | — |
| +1 | K261027 | NOVEOS Specific IgE (sIgE); Capture Reagent F014, Soybean (Glycine max)… | Hycor Biomedical | 2026 | — |
| +1 | K260591 | NOVEOS Specific IgE (sIgE);Capture Reagent F010, Sesame Seed (Sesamum… | Hycor Biomedical | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 2 | 0 |
| 2012 | 1 | 0 |
| 2013 | 3 | 0 |
| 2015 | 1 | 0 |
| 2016 | 3 | 0 |
| 2017 | 1 | 0 |
| 2018 | 2 | 0 |
| 2019 | 2 | 0 |
| 2020 | 2 | 0 |
| 2022 | 2 | 0 |
| 2024 | 1 | 0 |
| 2025 | 2 | 0 |
| 2026 | 5 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DHB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DHB device
- #1 K260331 IMMULITE 2000 3gAllergy Specific IgE Vantage…score 12.3 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K962274 | Unicap 100Summary page 1…UniCAP Specific IgE 82DHB II 866.5750 Substantial Equivalence to: UniCAP Specific IgE (K962274) Pharmacia Diagnostics AB Premarket Notification Special 510(k): Device Modification Page 13 of 16 Pharmacia… | 1996 |
What descends from it? (30)
See all 3027 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K161899 | ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip, ImmunoCAP Total IgE… | 2016 | 1 |
| K113841 | Immunocap Allergen Components Bundle | 2012 | 1 |
| K101251 | Immunocap Allergen D202, Allergen Component Nder P 1, House Dust Mite, Immunocap… | 2011 | 1 |
| K261027 | NOVEOS Specific IgE (sIgE); Capture Reagent F014, Soybean (Glycine max); Capture Reagent… | 2026 | 0 |
| K260591 | NOVEOS Specific IgE (sIgE);Capture Reagent F010, Sesame Seed (Sesamum indicum);Capture… | 2026 | 0 |
| K260280 | NOVEOS Specific IgE (sIgE); Capture Reagent F004, Wheat (Triticum aestivum); Capture… | 2026 | 0 |
| K260059 | NOVEOS Specific IgE (sIgE); Capture Reagent F018, Brazil Nut (Bertholletia excelsa)… | 2026 | 0 |
| K252775 | NOVEOS Specific IgE (sIgE): Capture Reagent F013, Peanut (Arachis hypogaea); Capture… | 2026 | 0 |
| K252493 | NOVEOS Specific IgE (sIgE); Capture Reagent F024, Shrimp (Shrimp spp.); Capture Reagent… | 2025 | 0 |
| K242531 | NOVEOS Specific IgE (sIgE) Assay; Capture Reagent G010, Johnson Grass (Sorghum… | 2025 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Jul 9, 2019 | Class II | Z-2397-2019 | Under Investigation by firm | code 7-102 Liquid Sensor Error |
| Dec 18, 2017 | Class II | Z-1312-2018 | Device Design | The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met. |
| Dec 18, 2017 | Class II | Z-1313-2018 | Device Design | The stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All DHB devicesDHB System, Test, Radioallergosorbent (Rast) Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DHB
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DHB
90in 2019
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DHB
14in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DHB
6in 2025
MAUDE reports naming product code DHB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 1 |
| 2009 | 7 | 118 | 0 | 0 |
| 2010 | 3 | 247 | 0 | 0 |
| 2011 | 5 | 405 | 0 | 1 |
| 2012 | 3 | 260 | 1 | 2 |
| 2013 | 5 | 257 | 0 | 0 |
| 2014 | 1 | — | 1 | 0 |
| 2015 | 1 | — | 0 | 1 |
| 2016 | 2 | — | 0 | 0 |
| 2017 | 1 | — | 1 | 11 |
| 2018 | 2 | — | 1 | 6 |
| 2019 | 3 | 90 | 0 | 4 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 7 |
| 2022 | 2 | — | 3 | 1 |
| 2023 | 0 | — | 0 | 6 |
| 2024 | 0 | — | 0 | 10 |
| 2025 | 2 | — | 14 | 6 |
| 2026 | 6 | 138 | 0 | — |
What is it indicated for?
UniCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. UniCAP Specific IgE is to be used with the instrument ImmunoCAP/UniCAP 250 and ImmunoCAP/UniCAP 1000. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories. The UniCAP Specific IgE is…
Read the full statement (145 words)
UniCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. UniCAP Specific IgE is to be used with the instrument ImmunoCAP/UniCAP 250 and ImmunoCAP/UniCAP 1000. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories.
The UniCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. UniCAP Specific IgE is to be used with the instrument ImmunoCAP 100/UniCAP 100. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories, as well as physician office laboratories.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051218 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051218: Modification to: Unicap Specific Ige.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051218
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026